What's New in Screening and Treatment for Lobular Breast Cancer

On September 12, 2023, the Lobular Breast Cancer Alliance (LBCA) hosted this live webinar that provided attendees with an opportunity to hear from three panelists who discussed the screening and treatment of invasive lobular carcinoma (ILC) from their specific clinical perspectives.
First, Tali Amir, MD, from Memorial Sloan Kettering Cancer Center, shared information on ILC detection and surveillance. Next, Anita Mamtani, MD, FACS, also from Memorial Sloan Kettering Cancer Center, presented information on ILC and surgery. Finally, LBCA Scientific Advisory Board Immediate Past Chair Rinath Jeselsohn, MD, spoke about current ILC treatment and the future direction of treatment. This was followed by a Q&A session.
PLEASE NOTE: We are not able to provide medical advice.
LBCA is grateful to Seagen Inc. for their support that has helped to make this webinar possible.

[@carebear6069]

Why does no one discuss Metabolic Therapy as an adjuvant treatment?

[@Lisa-xp5qj]

Excellent lecture!! thank you!

[@yorkiepeachygirlllc761]

What's the long term effectiveness of Tamoxifen for POST menopausal women with DMX.?